[go: up one dir, main page]

RU95112520A - APPLICATION 4'-IODO-4'-DEOXIDOXORUBICINE FOR THE TREATMENT OF AMYLOIDOSIS, METHOD OF TREATMENT OF AMYLOIDOSIS - Google Patents

APPLICATION 4'-IODO-4'-DEOXIDOXORUBICINE FOR THE TREATMENT OF AMYLOIDOSIS, METHOD OF TREATMENT OF AMYLOIDOSIS

Info

Publication number
RU95112520A
RU95112520A RU95112520/14A RU95112520A RU95112520A RU 95112520 A RU95112520 A RU 95112520A RU 95112520/14 A RU95112520/14 A RU 95112520/14A RU 95112520 A RU95112520 A RU 95112520A RU 95112520 A RU95112520 A RU 95112520A
Authority
RU
Russia
Prior art keywords
treatment
amyloidosis
pharmaceutically acceptable
iodo
deoxydoxorubicin
Prior art date
Application number
RU95112520/14A
Other languages
Russian (ru)
Other versions
RU2155589C2 (en
Inventor
МЕРЛИНИ Джампаоло
ДЖАННИ Лука
Original Assignee
Поликлинико Сан Маттео, Иституто ди риковеро э Кура а Караттере Шиентифико ди Диритто Публико
Иституто Национале Пер ло Студио э ла Кура Деи Тумори
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IT93MI001800A external-priority patent/IT1265055B1/en
Priority claimed from ITMI940621A external-priority patent/IT1274032B/en
Application filed by Поликлинико Сан Маттео, Иституто ди риковеро э Кура а Караттере Шиентифико ди Диритто Публико, Иституто Национале Пер ло Студио э ла Кура Деи Тумори filed Critical Поликлинико Сан Маттео, Иституто ди риковеро э Кура а Караттере Шиентифико ди Диритто Публико
Publication of RU95112520A publication Critical patent/RU95112520A/en
Application granted granted Critical
Publication of RU2155589C2 publication Critical patent/RU2155589C2/en

Links

Claims (4)

1. Применение 4'-йод-4'-деоксидоксуробицина и его фармацевтически приемлемых солей для получения лекарственного препарата, пригодного для лечения амилоидоза.1. The use of 4'-iodine-4'-deoxydoxurobicin and its pharmaceutically acceptable salts for the manufacture of a medicament suitable for the treatment of amyloidosis. 2. Применение 4'-йод-4'-деоксидоксорубцина и его фармацевтически приемлемых солей для получения лекарственного препарата, пригодного для лечения болезни Альцгеймера и синдрома Дауна. 2. The use of 4'-iodine-4'-deoxydoxorubicin and its pharmaceutically acceptable salts for the manufacture of a medicament suitable for the treatment of Alzheimer's disease and Down syndrome. 3. Способ лечения амилоидоза, в частности лечения болезни Альцгеймера и синдрома Дауна, отличающийся тем, что он включает введение пациенту терапевтически эффективного количества 4'-йод-4'-деоксидоксорубицина или его фармацевтически приемлемых солей. 3. A method of treating amyloidosis, in particular treating Alzheimer's disease and Down syndrome, characterized in that it comprises administering to the patient a therapeutically effective amount of 4'-iodo-4'-deoxydoxorubicin or its pharmaceutically acceptable salts. 4. Применение п.1 и 2, отличающееся тем, что 4'-йод-4'-деоксидоксорубицин вводят пациенту внутривенно при еженедельной дозировке от 15 - 30 мг/м2 площади тела в виде раствора, приготовленного стандартным способом, содержащего фармацевтически приемлемые носители или разбавители, в течение в интервале 2 - 4 недель.4. The use of claim 1 and 2, characterized in that 4'-iodine-4'-deoxydoxorubicin is administered to the patient intravenously at a weekly dosage of 15-30 mg / m 2 body area in the form of a solution prepared in a standard manner containing pharmaceutically acceptable carriers or diluents, over a period of 2 to 4 weeks.
RU95112520/14A 1993-08-06 1994-07-29 Use of 4'-iodo-4'-deoxydoxorubicine for treatment of patients with amyloidosis, method of treatment of patients with amyloidosis RU2155589C2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
ITMI93A001800 1993-08-06
IT93MI001800A IT1265055B1 (en) 1993-08-06 1993-08-06 Use of 4'-deoxy-4'-iododoxorubicin for the treatment of amyloidosis
ITMI940621A IT1274032B (en) 1994-03-31 1994-03-31 Use of 4'-deoxy-4'-iododoxorubicin for the treatment of amyloidosis in Altzheimers disease
ITMI94A000621 1994-03-31

Publications (2)

Publication Number Publication Date
RU95112520A true RU95112520A (en) 1997-11-27
RU2155589C2 RU2155589C2 (en) 2000-09-10

Family

ID=26331037

Family Applications (1)

Application Number Title Priority Date Filing Date
RU95112520/14A RU2155589C2 (en) 1993-08-06 1994-07-29 Use of 4'-iodo-4'-deoxydoxorubicine for treatment of patients with amyloidosis, method of treatment of patients with amyloidosis

Country Status (19)

Country Link
US (1) US5637572A (en)
EP (1) EP0663832B1 (en)
JP (1) JPH08505401A (en)
KR (1) KR100270465B1 (en)
AT (1) ATE200624T1 (en)
AU (1) AU687432B2 (en)
CA (1) CA2142349A1 (en)
DE (1) DE69427116T2 (en)
DK (1) DK0663832T3 (en)
ES (1) ES2157984T3 (en)
GR (1) GR3036221T3 (en)
HU (1) HU217546B (en)
IL (1) IL110289A (en)
MY (1) MY111755A (en)
PL (1) PL180000B1 (en)
PT (1) PT663832E (en)
RU (1) RU2155589C2 (en)
UA (1) UA29461C2 (en)
WO (1) WO1995004538A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9418260D0 (en) * 1994-09-09 1994-10-26 Erba Carlo Spa Anthracycline derivatives
GB9516349D0 (en) * 1995-08-09 1995-10-11 Pharmacia Spa Aza-anthracyclinone derivatives
US6001331A (en) * 1996-01-24 1999-12-14 Warner-Lambert Company Method of imaging amyloid deposits
GB9805082D0 (en) 1998-03-10 1998-05-06 Pharmacia & Upjohn Spa Heterocyclyl anthracyclinone derivatives
GB9805080D0 (en) 1998-03-10 1998-05-06 Pharmacia & Upjohn Spa Amino anthracyclinone derivatives
PL237739B1 (en) 2018-06-06 2021-05-17 Univ Gdanski Genistein and its composition to be used in treatment of Alzheimer disease

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4438105A (en) * 1982-04-19 1984-03-20 Farmaitalia Carlo Erba S.P.A 4'-Iododerivatives of anthracycline glycosides
GB8701381D0 (en) * 1987-01-22 1987-02-25 Erba Farmitalia Antitumor agent
WO1990011080A1 (en) * 1989-03-24 1990-10-04 Daiichi Pharmaceutical Co., Ltd. Drug for improving brain function
GB2238540B (en) * 1989-11-29 1993-09-29 Erba Carlo Spa 13-deoxy-4'-deoxy-4'-iodoanthracyclines
JPH0725786A (en) * 1990-05-16 1995-01-27 Univ Rockefeller Medical treatment of amyloidosis accompanying alzheimer desease
NZ241606A (en) * 1991-02-28 1994-08-26 Iaf Biochem Int Heteroanthracycline antitumor analogs, preparation and pharmaceutical compositions thereof; intermediates therefor
JP4142304B2 (en) * 2001-10-22 2008-09-03 株式会社安川電機 Arc welding robot

Similar Documents

Publication Publication Date Title
NO963493L (en) Means to promote platelet formation
RU95107881A (en) Pharmaceutical composition for allergic disease treatment, method of antihistamine treatment, use of composition for medicinal preparation preparing
RU95113492A (en) THERAPEUTIC COMBINATION CONTAINING THE HUMAN INTERFERON, ITS APPLICATION, PHARMACEUTICAL DRUG, PACKAGING AND METHOD OF TREATMENT
KR950703951A (en) ANTIPYRETIC AND ANALGESIC METHODS AND COMPOSITIONS CONTAINING OPTICALLY PURE R-KETOROLAC
RU98111594A (en) PHARMACEUTICAL COMPOSITIONS INCLUDING FLURBIPROFEN
RU95101385A (en) Products containing g-csf and tnf-binding protein
EP1201246A3 (en) Use of Thrombopoietin as a medicament for the therapy and prevention of thrombocytopenia
GB2285219B (en) Use of norastemizole for the treatment of allergic disorders
RU95113499A (en) METHOD FOR INCREASING URINITATION IN HUMAN, METHOD FOR REDUCING LEVELS OF CHOLESTEROL AND LOW DENSITY LIPOPROTEINS, APPLICATION OF (+) DOXAZOSINE
JP2003514025A5 (en)
RU95112520A (en) APPLICATION 4'-IODO-4'-DEOXIDOXORUBICINE FOR THE TREATMENT OF AMYLOIDOSIS, METHOD OF TREATMENT OF AMYLOIDOSIS
WO2001012214A3 (en) MYCOPHENOLATE MOFETIL IN ASSOCIATION WITH PEG-IFN-$g(a)
RU2002129298A (en) APPLICATION OF GALANTAMINE FOR THE TREATMENT OF PSYCHONEUROLOGICAL BEHAVIOR ASSOCIATED WITH ALZHEIMER'S DISEASE
GR3022608T3 (en) USE OF (E)-2-(p-FLUOROPHENETHYL)-3-FLUOROALLYLAMINE IN THE TREATEMENT OF ALZHEIMER'S DISEASE.
RU94023600A (en) METHOD FOR TREATING HEMOCHROMATOSIS
US4885288A (en) Pharmaceutical compositions containing lysine acetylsalicylate
US4742076A (en) Etodolac for lowering rheumatoid factor
RU2000110676A (en) METHOD FOR CONSERVATIVE TREATMENT OF URETHRIC STRICTURES
KR930019207A (en) Use of L-carnitine for the treatment of carnitine deficient HIV-serum positive patients
RU93018067A (en) METHOD OF TREATMENT FOR CAVIARY FORM OF TUBERCULOSIS
KR890001558A (en) Zephyron and its pharmaceutically acceptable acid addition salts alleviate panic disorder
NO961180L (en) Transdermal device containing (E) -2- (p-fluorophenethyl) -3-fluoroallylamine for the treatment of Alzheimer's disease
RU93044256A (en) METHOD OF TREATING SARKOIDOSE
RU99104174A (en) TREATMENT OF PSYCHOTIC DISORDERS
RU96112181A (en) TREATMENT OF RHEUMATOID ARTHRITIS